Manpreet Singh
CEMTREXAbout Manpreet Singh
Manpreet Singh (age 40) has served as an independent director of Cemtrex (CETX) since November 1, 2021. He is the founder and Chief Investment Officer of Singh Capital Partners, a multifamily office investing across venture capital, real estate, and growth equity; he is a CFA charterholder with an MBA from The Wharton School (Entrepreneurship, Finance, Real Estate) and a B.S. in Finance from the University of Maryland, College Park .
Past Roles
| Organization | Role | Tenure | Committees / Impact |
|---|---|---|---|
| Singh Capital Partners (SCP) | Founder & Chief Investment Officer | Not disclosed | Leads investments in North America, Europe, Asia |
External Roles
| Organization | Role | Category | Committees / Notes |
|---|---|---|---|
| AcquCo | Director | Private company | Not disclosed |
| US Inspect | Director | Private company | Not disclosed |
| Embrace Software | Director | Private company | Not disclosed |
| Snowball Industries | Director | Private company | Not disclosed |
| Shukr Investments | Director | Private company | Not disclosed |
| Suburban Hospital (Johns Hopkins Medicine) | Board member | Non-profit/healthcare | Not disclosed |
| Dingman Center, Smith School of Business | Board member | Academic | Not disclosed |
Board Governance
- Independence: The Board determined Messrs. Kwon, Singh, and Filipov are independent under NASDAQ rules .
- Committee assignments: Audit Committee member (independent); committee chaired by Metodi Filipov .
- Board meetings/attendance: Four Board meetings in FY2024; no Director attended less than 75% of aggregate meetings .
- Annual shareholder meeting attendance: Manpreet Singh was not in attendance at last year’s annual meeting (along with Kwon and Filipov) .
- Board structure: Company is a NASDAQ “Controlled Company” and does not maintain Compensation or Nominating Committees; Audit Committee is the only standing committee .
Fixed Compensation
| Component | Amount | Notes |
|---|---|---|
| Quarterly cash retainer | $5,000 | Applies to Board members; expenses reimbursed |
| Annualized equivalent (computed) | $20,000 | 4 × $5,000; no separate meeting or chair fees disclosed |
Performance Compensation
- No performance-based or equity-based director compensation is disclosed for directors; the proxy states Board members receive a quarterly cash retainer and expense reimbursement, with no additional elements specified .
Other Directorships & Interlocks
| Category | Details |
|---|---|
| Current public company boards | None disclosed for Manpreet Singh . |
| Committee roles at other public companies | None disclosed . |
| Potential interlocks (competitors/suppliers/customers) | None disclosed . |
Expertise & Qualifications
- Finance and investing expertise: Founder/CIO of SCP; CFA charterholder .
- Education: MBA (Wharton) in Entrepreneurship, Finance, Real Estate; B.S. Finance (UMD) .
- Board role: Independent director; Audit Committee member (not designated the audit committee financial expert; Filipov is designated) .
Equity Ownership
As of the record date March 18, 2025.
| Security | Beneficially Owned | Ownership % | Notes |
|---|---|---|---|
| Common Stock | 2 shares | <1% | “Less than one percent of outstanding shares” per proxy’s notation . |
| Series 1 Preferred Stock | 0 | N/A | No holdings disclosed . |
| Series C Preferred Stock | 0 | N/A | No holdings disclosed . |
| Pledged shares | Not disclosed | — | No pledging disclosed in proxy . |
Insider Filings & Trading
| Item | Status / Detail |
|---|---|
| Section 16 compliance (FY2024) | Company reports all Reporting Persons complied timely, except one late Form 4 by Mr. Govil; no exceptions noted for Mr. Singh . |
| Form 4 transactions | Not detailed in proxy; see Section 16 note above . |
Governance Assessment
-
Strengths
- Independent director with substantive finance/investing credentials; serves on Audit Committee, supporting financial oversight .
- Board reports adequate meeting attendance (no director under 75%) during FY2024, indicating baseline engagement in formal Board duties .
- Director compensation appears modest and solely cash-based ($5,000 quarterly), supporting independence and reducing pay-related conflicts .
-
Areas to monitor / RED FLAGS
- Very limited “skin in the game”: beneficial ownership of only 2 common shares (<1%), which may signal weaker alignment with common shareholders .
- Controlled company exemptions: absence of Compensation and Nominating Committees concentrates oversight and may weaken checks/balances; raises reliance on Audit Committee for broader governance risk surveillance .
- Related-party exposures with the CEO’s controlled entities (e.g., receivables and royalties with CXR, Inc.) represent ongoing conflict risk that the Audit Committee (including Mr. Singh) must actively oversee: $685,788 trade receivables due from CXR, Inc. as of September 30, 2024; $215,408 royalties current; $456,611 long-term royalties; $665,520 revenue recognized from CXR in FY2024 . Historical related-party matters also include Ducon Technologies payables/receivables and unresolved notes related to Aron Govil, further elevating related-party oversight demands .
- Shareholder meeting presence: Singh was not in attendance at last year’s annual meeting, a soft negative for investor engagement optics .